Literature DB >> 2542829

Role of alpha-adrenergic mechanism in effects of morphine on the hypothalamo-pituitary-adrenocortical and cardiovascular systems in the rat.

S Suemaru1, M F Dallman, D N Darlington, C S Cascio, J Shinsako.   

Abstract

The role of alpha-adrenergic mechanism in the acute effects of morphine in the hypothalamo-pituitary-adrenocortical (HPA) and cardiovascular (CV) systems, and the interrelationship between the HPA and CV responses to alpha-adrenoceptor antagonists and/or morphine were studied by peripheral administration of prazosin, a selective alpha 1-adrenoceptor antagonist, and yohimbine, a selective alpha 2-adrenoceptor antagonist, in conscious, unstressed or ether-stressed rats. The test substances were administered intravenously or intraperitoneally in chronically cannulated or noncannulated rats. In the i.v. experiment, morphine (1 mg/100 g BW) rapidly induced a pronounced bradycardia and a short-lasting fall in blood pressure (BP), followed by a rise in BP, and increased plasma corticosterone concentration. Prazosin (0.5 mg/kg BW) induced a rapid fall in BP and tachycardia, and increased plasma corticosterone concentration. Pretreatment with prazosin did not block the effect of morphine on the CV system, but abolished the morphine-induced increment in plasma corticosterone concentration. Yohimbine (0.5 mg/kg BW) induced a rapid and a subsequent slowly developing rise in BP and tachycardia, and increased plasma corticosterone concentration. Pretreatment with yohimbine did not block the effect of morphine on the CV system nor alter the stimulatory effect of morphine on the secretion of corticosterone. In the intraperitoneal experiment, morphine (2 mg/100 g BW) stimulated the secretion of adrenocorticotropic hormone (ACTH) and corticosterone and prazosin (1 mg/kg BW) stimulated the secretion of corticosterone, but pretreatment with prazosin reduced the morphine-induced increment in plasma corticosterone concentration in unstressed rats. In stressed rats, morphine reduced the stress-induced increment in plasma ACTH and corticosterone concentrations and prazosin also reduced the stress-induced increment in plasma corticosterone concentration. Pretreatment with prazosin did not alter the inhibitory effect of morphine...

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2542829     DOI: 10.1159/000125112

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  11 in total

1.  Medial prefrontal cortex neuronal activation and synaptic alterations after stress-induced reinstatement of palatable food seeking: a study using c-fos-GFP transgenic female rats.

Authors:  Carlo Cifani; Eisuke Koya; Brittany M Navarre; Donna J Calu; Michael H Baumann; Nathan J Marchant; Qing-Rong Liu; Thi Khuc; James Pickel; Carl R Lupica; Yavin Shaham; Bruce T Hope
Journal:  J Neurosci       Date:  2012-06-20       Impact factor: 6.167

Review 2.  Central neuroregulation of hypothalamic corticotropin-releasing hormone (CRH-41) secretion.

Authors:  S Tsagarakis; A Grossman
Journal:  J Endocrinol Invest       Date:  1990-10       Impact factor: 4.256

3.  The anxiogenic drug yohimbine reinstates palatable food seeking in a rat relapse model: a role of CRF1 receptors.

Authors:  Udi E Ghitza; Sarah M Gray; David H Epstein; Kenner C Rice; Yavin Shaham
Journal:  Neuropsychopharmacology       Date:  2005-12-07       Impact factor: 7.853

4.  Nicotine self-administration and reinstatement of nicotine-seeking in male and female rats.

Authors:  Matthew W Feltenstein; Shannon M Ghee; Ronald E See
Journal:  Drug Alcohol Depend       Date:  2011-09-25       Impact factor: 4.492

Review 5.  Modeling relapse in animals.

Authors:  Rémi Martin-Fardon; Friedbert Weiss
Journal:  Curr Top Behav Neurosci       Date:  2013

6.  Enhancement of cue-induced reinstatement of cocaine-seeking in rats by yohimbine: sex differences and the role of the estrous cycle.

Authors:  Matthew W Feltenstein; Alisha R Henderson; Ronald E See
Journal:  Psychopharmacology (Berl)       Date:  2011-02-11       Impact factor: 4.530

7.  Effects of naloxone on diurnal rhythms in mood and endocrine function: a dose-response study in man.

Authors:  A F Martin del Campo; J H Dowson; J Herbert; E S Paykel
Journal:  Psychopharmacology (Berl)       Date:  1994-05       Impact factor: 4.530

8.  Alterations in ethanol seeking and self-administration following yohimbine in selectively bred alcohol-preferring (P) and high alcohol drinking (HAD-2) rats.

Authors:  Megan L Bertholomey; Terril L Verplaetse; Cristine L Czachowski
Journal:  Behav Brain Res       Date:  2012-10-26       Impact factor: 3.332

9.  A rodent "self-report" measure of methamphetamine craving? Rat ultrasonic vocalizations during methamphetamine self-administration, extinction, and reinstatement.

Authors:  Stephen V Mahler; David E Moorman; Matthew W Feltenstein; Brittney M Cox; Katelyn B Ogburn; Michal Bachar; Justin T McGonigal; Shannon M Ghee; Ronald E See
Journal:  Behav Brain Res       Date:  2012-08-24       Impact factor: 3.332

10.  Enhanced immune sensitivity to stress following chronic morphine exposure.

Authors:  Kimberly A Ballard; Trisha C Pellegrino; Norma C Alonzo; Alexandria L Nugent; Barbara M Bayer
Journal:  J Neuroimmune Pharmacol       Date:  2006-03       Impact factor: 7.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.